JP2019099571A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019099571A5 JP2019099571A5 JP2018223465A JP2018223465A JP2019099571A5 JP 2019099571 A5 JP2019099571 A5 JP 2019099571A5 JP 2018223465 A JP2018223465 A JP 2018223465A JP 2018223465 A JP2018223465 A JP 2018223465A JP 2019099571 A5 JP2019099571 A5 JP 2019099571A5
- Authority
- JP
- Japan
- Prior art keywords
- invention described
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024045935A JP2024079762A (ja) | 2017-11-29 | 2024-03-22 | Ｇｌｐ－１受容体アゴニスト作用を持つピラゾロピリジン誘導体を含有する医薬組成物 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017228661 | 2017-11-29 | ||
| JP2017228661 | 2017-11-29 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024045935A Division JP2024079762A (ja) | 2017-11-29 | 2024-03-22 | Ｇｌｐ－１受容体アゴニスト作用を持つピラゾロピリジン誘導体を含有する医薬組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019099571A JP2019099571A (ja) | 2019-06-24 |
| JP2019099571A5 true JP2019099571A5 (ko) | 2022-01-06 |
| JP7461104B2 JP7461104B2 (ja) | 2024-04-03 |
Family
ID=66975925
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018223465A Active JP7461104B2 (ja) | 2017-11-29 | 2018-11-29 | Ｇｌｐ－１受容体アゴニスト作用を持つピラゾロピリジン誘導体を含有する医薬組成物 |
| JP2024045935A Pending JP2024079762A (ja) | 2017-11-29 | 2024-03-22 | Ｇｌｐ－１受容体アゴニスト作用を持つピラゾロピリジン誘導体を含有する医薬組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024045935A Pending JP2024079762A (ja) | 2017-11-29 | 2024-03-22 | Ｇｌｐ－１受容体アゴニスト作用を持つピラゾロピリジン誘導体を含有する医薬組成物 |
Country Status (1)
| Country | Link |
|---|---|
| JP (2) | JP7461104B2 (ko) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110618208A (zh) * | 2019-09-10 | 2019-12-27 | 威海迪素制药有限公司 | 一种（s）-（+）-3-羟基四氢呋喃对映异构体含量检测方法 |
| JP2023513272A (ja) | 2020-02-07 | 2023-03-30 | ガシャーブラム・バイオ・インコーポレイテッド | ヘテロ環ｇｌｐ－１アゴニスト |
| CN116615430A (zh) * | 2020-09-07 | 2023-08-18 | 加舒布鲁姆生物公司 | 杂环glp-1激动剂 |
| WO2023016546A1 (en) * | 2021-08-12 | 2023-02-16 | Gasherbrum Bio, Inc. | Heterocyclic glp-1 agonists |
| WO2023220109A1 (en) * | 2022-05-11 | 2023-11-16 | Eli Lilly And Company | Glp1 pharmaceutical compositions |
| WO2023220112A1 (en) * | 2022-05-11 | 2023-11-16 | Eli Lilly And Company | Glp1 tablet compositions |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2635838T3 (es) * | 2002-08-26 | 2017-10-05 | Takeda Pharmaceutical Company Limited | Compuesto modulador de receptores de calcio y su uso |
| CA2670636A1 (en) * | 2006-11-27 | 2008-06-05 | H. Lundbeck A/S | Heteroaryl amide derivatives |
| AU2010232750B2 (en) * | 2009-03-30 | 2015-10-29 | Vtv Therapeutics Llc | Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof |
| WO2014122067A1 (en) * | 2013-02-06 | 2014-08-14 | Boehringer Ingelheim International Gmbh | New indanyloxydihydrobenzofuranylacetic acids |
| EP2993174A1 (en) * | 2014-09-08 | 2016-03-09 | Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH | Pyrazolopyridine derivatives and their use in therapy |
| JOP20190060A1 (ar) | 2016-09-26 | 2019-03-26 | Chugai Pharmaceutical Co Ltd | مشتق بيرازولو بيريدين له تأثير مساعد لمستقبل glp-1 |
-
2018
- 2018-11-29 JP JP2018223465A patent/JP7461104B2/ja active Active
-
2024
- 2024-03-22 JP JP2024045935A patent/JP2024079762A/ja active Pending